Study Could Weaken Merck's Vioxx Defense: Report
A new study which reportedly lends credibility to evidence that Merck & Co.'s Vioxx increased the risk of heart attacks in patients immediately after they started taking the drug could drive...To view the full article, register now.
Already a subscriber? Click here to view full article